Educational Activities Archives

Buprenorphine/Naloxone Maintenance Treatment Physician/Office Information

Throughout this webinar, attendees will be introduced to the foundational aspects of creating and sustaining productive community-based research partnerships. We will highlight successful case studies and models that demonstrate the practical application of these collaborations, showcasing how they can lead to the development of innovative, evidence-based treatment strategies specifically tailored for women. Key discussions will include case examples such as the integration of exercise and wellness programs and the enhancement of peer support efforts, illustrating the diverse ways in which partnerships can enrich treatment interventions. However, the primary focus will remain on the overarching strategies and principles that guide these successful collaborations. Designed for social workers, treatment professionals, researchers, and advocates, this webinar aims to equip participants with the knowledge and tools necessary to foster meaningful collaborations that can significantly impact women’s recovery journeys. Join us to learn how you can contribute to advancing women’s substance use disorder treatment through the power of community-based research partnerships.

The OUD Cascade of Care is a public health framework for monitoring population-level outcomes with an emphasis on MOUD initiation and retention. Buprenorphine treatment can be tailored under the Cascade framework based on patient risk level. For instance, patients with active fentanyl use who are naïve to buprenorphine often need more intensive services early in treatment compared to patients entering care already on buprenorphine, whether prescribed or otherwise.

Transitioning from jails and prisons back into the community can be especially difficult for people with opioid use disorders (OUD). Research suggests that opioid use overdose increases dramatically within the first 30 days of citizens returning to the community. Further, individuals recently released from incarceration face a risk of opioid overdose ten times greater than the general public. During these transitions it is critical that people receive seamless and appropriate resources in order to prevent overdose and return to use. This proper transition can help lower health care costs, hospitalizations and emergency department visits, as well as decrease mortality and recidivism for justice-involved individuals, yet at this time only 13 states have sought Medicaid waivers to provide SUD services pre-release. Join us today as we explore how programs can successfully develop services to ensure returning citizens receive appropriate care to address OUD.

Developed by AAAP and ASAM, this guideline focuses on the identification, diagnosis, treatment, and promotion of recovery for patients with stimulant use disorder, stimulant intoxication, and stimulant withdrawal.

Opioids are narcotic pain relievers that require a prescription from a healthcare professional. When taken as prescribed for short periods of time under the care of a medical professional, opioids can be a safe and effective pain management tool.